CAPR: Capricor Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 503.24
Enterprise Value ($M) 474.45
Book Value ($M) 145.46
Book Value / Share 3.18
Price / Book 3.46
NCAV ($M) 120.13
NCAV / Share 2.63
Price / NCAV 4.19

Profitability (mra)
Return on Invested Capital (ROIC) -0.38
Return on Assets (ROA) -1.11
Return on Equity (ROE) -2.44

Liquidity (mrq)
Quick Ratio 6.55
Current Ratio 6.55

Balance Sheet (mrq) ($M)
Current Assets 146.25
Assets 153.77
Liabilities 26.12
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 22.27
Operating Income -42.56
Net Income -40.47
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -40.00
Cash from Investing -116.18
Cash from Financing 152.77

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-30 13G/A Vanguard Group Inc 4.95 -0.56
02-05 13G/A BlackRock, Inc. 6.50 69.54
11-08 13G/A Highbridge Capital Management Llc 6.50 0.00
09-24 13G/A Nippon Shinyaku Co Ltd 18.90 65.21

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-14 10-Q variable UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2025-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-14 10-Q variable UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-20 1,153,686 3,244,083 35.56
2025-05-19 1,005,628 3,014,314 33.36
2025-05-16 937,312 3,067,107 30.56
2025-05-15 1,267,159 4,484,791 28.25

(click for more detail)

Similar Companies
BULL – Webull Corporation BYSI – BeyondSpring Inc.
CALC – CalciMedica, Inc. CASI – CASI Pharmaceuticals, Inc.
CDIO – Cardio Diagnostics Holdings, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Capricor Therapeutics